Medical Crossfire®: Considering Point-of-Care Testing in Your Practice Setting? Opportunities and Challenges for Implementation in Family Practice, Retail Pharmacies, and the ER

Release Date: December 20, 2019
Expiration Date: December 20, 2020
Media: Internet - based

Activity Overview

Point-of-care testing (POCTs) for detection of acute or chronic diseases in the outpatient or emergency department settings has made it possible to promptly establish the etiology of disease and facilitate diagnosis, monitoring, treatment, and referral decisions for a variety of these conditions. Utilization of POCT has steadily increased over the past 40 years since its initial introduction healthcare settings. Since it provides immediate results in non-laboratory settings, it supports a patient-centered approached to healthcare delivery. Therefore, it is crucial to empower clinicians at the “point-of-care”, including emergency room physicians, primary care/family practice physicians, and pharmacists, because they have the potential to significantly management strategies.

Benefits of Participating

• Learn about strategic measures to improve on care of patients that limit the risk of acute infections
• Learn about the shift towards early prevention and detection with the role of point-of- care testing, including ways to improve or implement strategies that may improve management
• Increase awareness of best practices to overcome challenges in implementation of point-of-care testing in various healthcare settings, including regulatory considerations

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Roche Diagnostics Incorporation.

Target Audience

This online educational activity is directed toward emergency room physicians, family practice/primary care physicians, retail pharmacists, nurse practitioners, physician assistants, hospital directors, and additional healthcare professionals who have an interest in learning more about the implementation of point-of-care testing in their practice settings.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

• Determine clinical implications and potential health benefits of implementing point-of-care testing in various healthcare settings.
• Review accuracy and key differentiators of CLIA-waived approved molecular testing for acute infections.
• Assess methods to overcome challenges in implementing point-of-care testing in various healthcare settings, including logistical and regulatory considerations.
• Analyze case-study models to apply best practices when implementing point-of-care testing in your own practice.

Faculty, Staff, and Planners’ Disclosures

Faculty

James H. Nichols, PhD, DABCC, FAACC
Professor of Pathology, Microbiology and Immunology
Medical Director, Clinical Chemistry and Point-of-Care Testing
Vanderbilt University School of Medicine
Nashville, TN

Disclosures: no relevant financial relationships with commercial interests.

John M. Hickner, MD, MSc
Professor Emeritus, Family Medicine
Michigan State University College of Human Medicine

Disclosures: no relevant financial relationships with commercial interests to disclose.

Allison Mari Dering-Anderson, BA, PharmD, RP, FAPhA
Clinical Associate Professor of Pharmacy
Department of Pharmacy Practice & Science
University of Nebraska College of Pharmacy
Omaha, NE

Disclosures: no relevant financial relationships with commercial interests to disclose.

Sean P. Collins, MD, MSc, FHFSA, FESC
Professor and Executive Vice Chair
Department of Emergency Medicine
Vanderbilt University Medical Center
Nashville, TN

Disclosures: Consultant: Ortho Clinical.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER^® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER^® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER^® is required by ACCME to resolve all COI. PER^® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or the company that provided commercial support.